345 related articles for article (PubMed ID: 24980914)
1. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies.
Agrawal V; Patel R; Patel M; Thanki K; Mishra S
Colloids Surf B Biointerfaces; 2021 May; 201():111652. PubMed ID: 33740733
[TBL] [Abstract][Full Text] [Related]
3. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
4. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
[TBL] [Abstract][Full Text] [Related]
5. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
6. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
7. Formulation evaluation of ketoconazole microemulsion-loaded hydrogel with nigella oil as a penetration enhancer.
Amra K; Momin M
J Cosmet Dermatol; 2019 Dec; 18(6):1742-1750. PubMed ID: 30980617
[TBL] [Abstract][Full Text] [Related]
8. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
9. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
10. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
11. Insights into drug delivery across the nail plate barrier.
Saner MV; Kulkarni AD; Pardeshi CV
J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
[TBL] [Abstract][Full Text] [Related]
12. Transungual Gel of Terbinafine Hydrochloride for the Management of Onychomycosis: Formulation, Optimization, and Evaluation.
Thatai P; Sapra B
AAPS PharmSciTech; 2017 Aug; 18(6):2316-2328. PubMed ID: 28116600
[TBL] [Abstract][Full Text] [Related]
13. Development of microemulgel formulations with varied permeation enhancers for transungual delivery of luliconazole in onychomycosis management.
Giri Y; Habibullah S; Dixit PK; Mahalik G; Mohanty B; Behera A
Colloids Surf B Biointerfaces; 2024 Feb; 234():113718. PubMed ID: 38176335
[TBL] [Abstract][Full Text] [Related]
14. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
Chouhan P; Saini TR
Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
[TBL] [Abstract][Full Text] [Related]
15. Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis.
Mahtab A; Anwar M; Mallick N; Naz Z; Jain GK; Ahmad FJ
AAPS PharmSciTech; 2016 Dec; 17(6):1477-1490. PubMed ID: 26857516
[TBL] [Abstract][Full Text] [Related]
16. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
17. Treatment and management strategies of onychomycosis.
Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
[TBL] [Abstract][Full Text] [Related]
18. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
19. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
Kumar N; Shishu
Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
[TBL] [Abstract][Full Text] [Related]
20. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
